Venture Investing
Investing in Calm | How to Buy Pre-IPO Shares
Securities.io may receive compensation when you use links to products we review. This does not influence our editorial evaluations. We are not a registered investment adviser; this is not investment advice. Read our affiliate disclosure.

Calm is a private consumer and enterprise mental-wellness company offering meditation, sleep, stress-management, and workplace-wellness products.
The company’s latest publicly verified priced financing remains the $75 million Series C announced in December 2020 at a $2 billion valuation. Investors should not treat operating announcements or secondary transactions as new primary funding.
What Is Calm?
Calm was founded in 2012 by Michael Acton Smith and Alex Tew. Its subscription products include guided meditation, sleep stories, music, breathing exercises, and programs offered through employers and healthcare channels.
The investment thesis depends on subscription retention, brand strength, enterprise adoption, clinical credibility, customer acquisition economics, competition, and the company’s ability to expand beyond a single consumer app.
Calm Funding and Valuation History
Calm disclosed approximately $28 million of financing before 2019, an $88 million round in February 2019, and a $75 million Series C in December 2020. The selected events total $191 million.
Calm Selected Funding Events
Verified disclosed or aggregated equity financing, USD millions; grants and secondary transactions excluded.
Verified Aug. 25, 2026
2018–2020 · $0–$100M
| Date | Round / type | Funding Raised | Reported valuation | Selected investors | Source |
|---|---|---|---|---|---|
| Dec. 8, 2020 | Series C | $75M | $2B | Lightspeed Venture Partners; Insight Partners; Marc Benioff; others | Calm |
| Feb. 6, 2019 | Series B | $88M | $1B | TPG Growth; Creative Artists Agency; Insight Venture Partners; others | Calm |
| Through 2018 | Earlier equity financing | $28M aggregate | Not disclosed | Prior investors | Calm |
Methodology: Calm’s February 2019 announcement said the company had raised $116 million after the $88 million round, implying approximately $28 million of earlier capital. Adding the $75 million Series C produces $191 million in selected disclosed financing. Grants, debt, secondaries, and other unallocated capital are excluded.
Investment Case
The investment case depends on Calm maintaining engagement and pricing power while expanding into employer and healthcare channels.
Recognized Brand
Calm is one of the best-known consumer brands in meditation and sleep content.
Subscription Model
Recurring subscriptions can produce predictable revenue when retention remains strong.
Enterprise Distribution
Employer and health-plan programs can diversify acquisition beyond app stores.
Content Library
A broad catalog can support engagement across sleep, stress, mindfulness, and relaxation.
Key Risks
Retention and Churn
Consumer wellness subscriptions can face high churn and changing engagement.
Customer Acquisition
Paid marketing and app-store economics may pressure margins.
Competition
Calm competes with meditation apps, fitness platforms, healthcare providers, and free content.
Clinical and Regulatory Risk
Health-related claims and enterprise use can increase evidence, compliance, and privacy requirements.
Valuation and Information
The last priced round is from 2020 and may not reflect current fundamentals.
Liquidity and Transfer Risk
Private shares may be scarce, restricted, and offered with additional fees.
How to Buy Calm Pre-IPO Shares
- Confirm that Calm remains private. Check for an SEC registration statement, a confirmed listing, or a material corporate transaction before pursuing private shares.
- Confirm your eligibility. Many late-stage secondary offerings use Regulation D and are limited to accredited investors. Individuals may qualify through net worth, income, or specified professional criteria.
- Find a live opportunity. Search registered private-market platforms or work with a qualified broker. A platform’s inclusion here does not mean it currently lists Calm.
- Review the security and vehicle. Determine whether the offer provides direct company shares or an interest in an SPV. Review share class, liquidation preferences, voting rights, information rights, and the investment manager.
- Evaluate price and fees. Compare the offered price and implied valuation with the latest financing while accounting for platform fees, carried interest, SPV expenses, and security rights.
- Review transfer and exit restrictions. Examine company consent requirements, rights of first refusal, holding periods, and what happens if an IPO or acquisition never occurs.
Accredited-investor criteria: Under current SEC criteria, an individual may qualify through net worth above $1 million excluding the primary residence; income above $200,000 individually or $300,000 with a spouse or partner in each of the prior two years with a reasonable expectation of the same; or certain professional criteria. Review the SEC criteria.
Where to Buy Calm Pre-IPO Shares
Availability on private marketplaces changes with seller supply, company transfer restrictions, jurisdiction, and investor eligibility. Always verify the live offering rather than assuming that Calm shares are available.
MicroVentures
MicroVentures facilitates primary and secondary private-company offerings. Eligibility, minimums, fees, investment structure, and availability vary by offering; Regulation D opportunities are limited to accredited investors.
View Available Private-Market Opportunities
Calm availability is not guaranteed. Review the specific offering documents before investing.
| Platform | Typical access model | What to verify |
|---|---|---|
| StartEngine Private | Late-stage private-company offerings | Current issuer availability, eligibility, minimum, fees, and vehicle structure |
| Forge Global | Private-company secondary marketplace and brokerage | Seller availability, accreditation, price, share class, and transaction costs |
| EquityZen | Private-company offerings that may use pooled vehicles | SPV terms, fees, minimum, economic rights, and transfer conditions |
| Rainmaker Securities | Broker-assisted private-company transactions | Security source, broker fees, settlement, and company approval |
| Hiive | Private-market bids, asks, and facilitated trades | Indicative versus executable pricing, fees, and transfer restrictions |
| EquityBee | Employee stock-option financing and related exposure | Contract structure, payoff terms, fees, and whether exposure is direct or indirect |
| Augment | Private-market transaction platform | Counterparty, price, share class, fees, and settlement terms |
Calm Valuation and IPO Outlook
We did not find a later company-confirmed priced equity round after the December 2020 Series C. The $2 billion valuation should therefore be treated as historical rather than current market evidence.
Any private offer should be evaluated using current subscribers, retention, revenue, margins, channel mix, share class, fees, and transfer restrictions.
Investing in Calm Pre-IPO Shares | Conclusion
Calm offers exposure to consumer and enterprise mental-wellness products through a recognized subscription brand.
The opportunity carries retention, acquisition-cost, competition, clinical, valuation, information, and liquidity risks. Investors should verify recent operating data and the exact security.
Explore other pre-IPO investment opportunities.
Primary and Supporting Sources
- Calm Series C and $2 billion valuation announcement
- Calm Series B and cumulative funding announcement
- Calm company blog
Disclaimer: This article is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Private securities can result in the loss of the entire investment and may remain illiquid indefinitely. Company and marketplace availability can change without notice. Verify all terms in the applicable offering documents and consult qualified professional advisers where appropriate.












